Sorrento Therapeutics (SRNE) Stock Chart & Stock Price History → A new way to collect income from stocks (From DTI) (Ad) Free SRNE Stock Alerts $0.02 0.00 (0.00%) (As of 10:16 AM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsSocial MediaSustainability Sorrento Therapeutics Stock Price Performance5 Day Performance-25.00%1 Month Performance+87.50%3 Month Performance-40.00%6 Month Performance-80.69%Year-To-Date Performance-87.85%1 Year Performance-95.54% Receive SRNE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. SRNE Stock Chart for Wednesday, April, 24, 2024 SRNE Chart by TradingView Sorrento Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$0.02$0.02$0.02$0.0256,236 shs$8.27 million04/22/2024$0.02$0.02-25.00%$0.02$0.01136,932 shs$8.27 million04/19/2024$0.03$0.02-28.57%$0.05$0.00198,999 shs$11.03 million04/18/2024$0.03$0.03$0.03$0.0242,473 shs$15.44 million04/17/2024$0.03$0.03+1.82%$0.04$0.0242,473 shs$15.44 million04/16/2024$0.03$0.03-8.33%$0.04$0.0253,447 shs$12.98 million Get the Latest News and Ratings for SRNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$0.03$0.03$0.03$0.02150,984 shs$14.16 million04/12/2024$0.03$0.03-12.12%$0.04$0.0013,730 shs$13.69 million04/11/2024$0.02$0.03+83.33%$0.04$0.00154,163 shs$15.57 million04/10/2024$0.02$0.02-10.00%$0.04$0.00293,864 shs$8.49 million04/09/2024$0.01$0.02+42.86%$0.03$0.01257,119 shs$9.44 million04/08/2024$0.01$0.01$0.02$0.01323,711 shs$6.61 million04/05/2024$0.01$0.01$0.02$0.00261,534 shs$4.72 million04/04/2024$0.01$0.01$0.03$0.00230,923 shs$4.72 million04/03/2024$0.01$0.01$0.01$0.01148,232 shs$4.72 million04/02/2024$0.01$0.01+25.00%$0.01$0.01148,232 shs$4.72 million04/01/2024$0.01$0.01$0.01$0.00199,234 shs$3.78 million03/29/2024$0.01$0.01$0.01$0.00199,234 shs$3.78 million03/28/2024$0.01$0.01-11.11%$0.01$0.01210,550 shs$3.78 million03/27/2024$0.01$0.01$0.01$0.01153,597 shs$4.25 million03/26/2024$0.01$0.01+12.50%$0.02$0.0161,686 shs$4.25 million03/25/2024$0.01$0.01$0.01$0.01103,819 shs$3.78 million03/22/2024$0.02$0.01-60.00%$0.01$0.01103,819 shs$3.78 million03/21/2024$0.01$0.02+100.00%$0.02$0.0167,781 shs$9.44 million03/20/2024$0.01$0.01-9.09%$0.02$0.01226,387 shs$4.72 million03/19/2024$0.02$0.01-38.89%$0.02$0.01101,512 shs$5.19 million03/18/2024$0.02$0.02$0.02$0.0167,518 shs$8.49 million03/15/2024$0.01$0.02+38.46%$0.02$0.01144,543 shs$8.49 million03/14/2024$0.02$0.01-27.78%$0.02$0.01129,868 shs$6.13 million03/13/2024$0.01$0.02+80.00%$0.02$0.01144,543 shs$8.49 million03/12/2024$0.01$0.01-16.67%$0.03$0.01147,236 shs$4.72 million03/11/2024$0.02$0.01-42.86%$0.03$0.01147,236 shs$5.66 million03/08/2024$0.03$0.02-18.27%$0.03$0.02246,873 shs$10.03 million03/07/2024$0.03$0.03$0.03$0.02127,503 shs$12.27 million03/06/2024$0.02$0.03+30.00%$0.03$0.01127,503 shs$12.27 million03/05/2024$0.02$0.02$0.02$0.0154,407 shs$9.44 million03/04/2024$0.02$0.02$0.03$0.02199,315 shs$9.44 million03/01/2024$0.03$0.03$0.03$0.02112,678 shs$12.74 million02/29/2024$0.03$0.03+1.12%$0.03$0.02112,526 shs$12.74 million02/28/2024$0.03$0.03-4.64%$0.05$0.03195,283 shs$12.60 millionThousands of investors use this no cost solution | Do you? (Ad)In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage"02/27/2024$0.03$0.03$0.04$0.03117,697 shs$13.21 million02/26/2024$0.10$0.03-71.72%$0.04$0.03117,697 shs$13.21 million02/23/2024$0.04$0.04$0.04$0.03142,629 shs$17.70 million02/22/2024$0.03$0.04+20.97%$0.04$0.03142,629 shs$17.70 million02/21/2024$0.03$0.03+10.71%$0.03$0.0273,719 shs$14.63 million02/20/2024$0.03$0.03$0.05$0.02137,744 shs$13.21 million02/19/2024$0.03$0.03$0.05$0.02137,744 shs$13.21 million02/16/2024$0.05$0.05$0.05$0.02956,943 shs$22.65 million02/15/2024$0.03$0.05+92.00%$0.05$0.02956,943 shs$22.65 million02/14/2024$0.03$0.03$0.04$0.0222,989 shs$11.80 million02/13/2024$0.03$0.03$0.03$0.0172,381 shs$11.80 million02/12/2024$0.03$0.03$0.03$0.02156,951 shs$11.80 million02/09/2024$0.04$0.02-40.00%$0.10$0.014.71 million shs$10.62 million02/08/2024$0.04$0.04$0.04$0.02136,637 shs$17.70 million02/07/2024$0.02$0.04+87.50%$0.04$0.02136,637 shs$17.70 million02/06/2024$0.02$0.02-4.76%$0.05$0.011.12 million shs$9.44 million02/05/2024$0.02$0.02$0.05$0.02768,682 shs$9.91 million02/02/2024$0.05$0.05$0.05$0.03351,248 shs$25.48 million02/01/2024$0.04$0.05+27.06%$0.05$0.03351,248 shs$25.48 million01/31/2024$0.03$0.04+70.00%$0.06$0.00311,380 shs$20.06 million01/30/2024$0.03$0.03-10.71%$0.07$0.02312,436 shs$11.80 million01/29/2024$0.03$0.03$0.07$0.02601,531 shs$13.21 million01/26/2024$0.03$0.03$0.09$0.02510,709 shs$14.16 million01/25/2024$0.03$0.03+20.00%$0.04$0.01259,127 shs$14.16 million01/24/2024$0.03$0.03$0.04$0.01259,127 shs$11.80 million01/23/2024$0.03$0.03$0.06$0.02336,841 shs$11.80 million Related Companies: Coeptis Therapeutics Stock Chart Senti Biosciences Stock Chart Genetic Technologies Stock Chart Inhibikase Therapeutics Stock Chart Organovo Stock Chart BioCardia Stock Chart PharmaCyte Biotech Stock Chart Creative Medical Technology Stock Chart Chromocell Therapeutics Stock Chart Surrozen Stock Chart Receive SRNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SRNE) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingNew Trump BombshellThe Freeport SocietyThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
